7K4F
Cryo-EM structure of human TRPV6 in complex with (4- phenylcyclohexyl)piperazine inhibitor 31
Summary for 7K4F
| Entry DOI | 10.2210/pdb7k4f/pdb |
| Related | 7K4A 7K4B 7K4C 7K4D 7K4E |
| EMDB information | 22662 22663 22664 22665 22666 22667 |
| Descriptor | Transient receptor potential cation channel subfamily V member 6, 5-[(4-{cis-4-[3-(trifluoromethyl)phenyl]cyclohexyl}piperazin-1-yl)methyl]pyridin-2(1H)-one, CALCIUM ION (3 entities in total) |
| Functional Keywords | trpv6, ion channel, inhibitor, membrane protein, membrane protein-inhibitor complex, membrane protein/inhibitor |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 4 |
| Total formula weight | 310224.71 |
| Authors | Neuberger, A.,Nadezhdin, K.D.,Singh, A.K.,Sobolevsky, A.I. (deposition date: 2020-09-15, release date: 2020-12-09, Last modification date: 2024-03-06) |
| Primary citation | Bhardwaj, R.,Lindinger, S.,Neuberger, A.,Nadezhdin, K.D.,Singh, A.K.,Cunha, M.R.,Derler, I.,Gyimesi, G.,Reymond, J.L.,Hediger, M.A.,Romanin, C.,Sobolevsky, A.I. Inactivation-mimicking block of the epithelial calcium channel TRPV6. Sci Adv, 6:-, 2020 Cited by PubMed Abstract: Epithelial calcium channel TRPV6 plays vital roles in calcium homeostasis, and its dysregulation is implicated in multifactorial diseases, including cancers. Here, we study the molecular mechanism of selective nanomolar-affinity TRPV6 inhibition by (4-phenylcyclohexyl)piperazine derivatives (PCHPDs). We use x-ray crystallography and cryo-electron microscopy to solve the inhibitor-bound structures of TRPV6 and identify two types of inhibitor binding sites in the transmembrane region: (i) modulatory sites between the S1-S4 and pore domains normally occupied by lipids and (ii) the main site in the ion channel pore. Our structural data combined with mutagenesis, functional and computational approaches suggest that PCHPDs plug the open pore of TRPV6 and convert the channel into a nonconducting state, mimicking the action of calmodulin, which causes inactivation of TRPV6 channels under physiological conditions. This mechanism of inhibition explains the high selectivity and potency of PCHPDs and opens up unexplored avenues for the design of future-generation biomimetic drugs. PubMed: 33246965DOI: 10.1126/sciadv.abe1508 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.75 Å) |
Structure validation
Download full validation report
